Putnam BioRevolution ETF Rating → Trump’s “Tax Free” Retirement Strategy (From Gold Safe Exchange) (Ad) Free SYNB Stock Alerts $30.51 +0.03 (+0.10%) (As of 09:30 AM ET) Add Compare Share Share RatingsStock AnalysisChartHoldingsRatingsStock AnalysisChartHoldingsRatings Putnam BioRevolution ETF Aggregate Rating and Price Target (2024)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.SYNB Aggregate RatingModerate Buy2.73Holdings in SYNB have an aggregate rating of Moderate Buy based on 458 analyst ratings issued in the past year covering 31 companies (89.7% of the portfolio).SYNB Aggregate Price Target$36.2318.73% UpsideHigh Prediction$43.92Average Prediction$36.23Low Prediction$27.29Holdings in SYNB have an aggregate price target of $36.23 and a range of $27.29 to $43.92 covering 31 companies (89.7% of the portfolio).SYNB Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy2 Buy rating(s)Moderate Buy23 Moderate Buy rating(s)Hold5 Hold rating(s)Reduce1 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by Putnam BioRevolution ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 31 SYNB Holdings Export to ExcelWeightIn ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings7.66%NVDANVIDIA$898.73+1.3%5 of 5 stars2.95$944.05 5.0%42Analyst Forecast7.30%TMOThermo Fisher Scientific$590.46+2.2%5 of 5 stars2.71$607.35 2.9%176.69%DHRDanaher$252.34+0.4%5 of 5 stars2.64$267.31 5.9%14Dividend AnnouncementShort Interest ↓5.56%BIOBio-Rad Laboratories$280.64+1.2%5 of 5 stars2.80$461.00 64.3%5Earnings ReportAnalyst ForecastShort Interest ↑5.47%GOOGLAlphabet$168.12-1.1%4 of 5 stars2.89$190.60 13.4%36Short Interest ↓4.60%CTVACorteva$57.91+0.1%4 of 5 stars2.73$63.24 9.2%22Insider SellingShort Interest ↑4.49%NVZMYNovozymes A/S$60.40+0.1%4 of 5 stars2.673Short Interest ↓Gap Down4.24%ABBVAbbVie$161.08+0.4%4 of 5 stars2.77$174.31 8.2%13Earnings ReportShort Interest ↑3.93%ASNDAscendis Pharma A/S$133.68+0.4%1 of 5 stars2.88$173.88 30.1%83.57%LLYEli Lilly and Company$764.15-1.0%5 of 5 stars2.84$757.95 -0.8%19Earnings ReportDividend AnnouncementShort Interest ↓3.46%AVTRAvantor$24.74-0.1%5 of 5 stars2.75$26.71 8.0%16Positive News3.37%DDDuPont de Nemours$78.65-0.2%5 of 5 stars2.27$80.00 1.7%11Insider SellingShort Interest ↓3.16%REGNRegeneron Pharmaceuticals$974.78+0.7%4 of 5 stars2.70$981.71 0.7%202.88%ZTSZoetis$169.13+0.6%5 of 5 stars3.00$211.75 25.2%7Analyst ForecastShort Interest ↑2.62%AZNAstraZeneca$77.46-0.2%2 of 5 stars2.57$81.00 4.6%72.46%BIIBBiogen$222.32-0.2%5 of 5 stars2.65$290.92 30.9%26Positive News2.19%NGVTIngevity$54.22-0.5%2 of 5 stars2.33$55.00 1.4%6Analyst Forecast2.15%LULULululemon Athletica$350.91-0.6%5 of 5 stars2.67$474.79 35.3%30Analyst ForecastShort Interest ↓2.04%EXASExact Sciences$52.87-2.4%5 of 5 stars2.92$95.40 80.4%13Analyst ForecastShort Interest ↓Analyst RevisionNews Coverage1.92%PPGPPG Industries$135.46+0.8%5 of 5 stars2.47$155.47 14.8%17Insider BuyingShort Interest ↓Positive News1.51%BGBunge Global$105.21-0.2%4 of 5 stars2.70$121.00 15.0%10Dividend IncreasePositive News1.44%TWSTTwist Bioscience$41.77-3.3%2 of 5 stars3.00$42.50 1.7%6Insider Selling1.33%DARDarling Ingredients$45.40-1.3%5 of 5 stars2.80$72.55 59.8%10Short Interest ↑Positive News1.29%VRTXVertex Pharmaceuticals$420.01+0.2%4 of 5 stars2.48$432.18 2.9%25Earnings ReportAnalyst Forecast1.04%RCKTRocket Pharmaceuticals$23.00-1.4%5 of 5 stars2.89$52.13 126.6%9Earnings ReportAnalyst ForecastAnalyst Revision0.94%TECHBio-Techne$80.10+0.7%4 of 5 stars2.82$80.50 0.5%110.59%CRSPCRISPR Therapeutics$51.39-4.0%3 of 5 stars2.35$74.43 44.8%17Earnings ReportUpcoming EarningsAnalyst ForecastAnalyst RevisionNews Coverage0.56%DNAGinkgo Bioworks$0.74-20.0%2 of 5 stars2.00$2.20 199.1%5Earnings ReportAnalyst DowngradeShort Interest ↑Gap DownHigh Trading Volume0.44%ALNYAlnylam Pharmaceuticals$149.38-1.3%5 of 5 stars2.59$216.19 44.7%17Analyst ForecastShort Interest ↑Analyst Revision0.40%LNZALanzaTech Global$2.52+2.9%2 of 5 stars2.75$6.33 151.3%4Earnings ReportAnalyst ForecastShort Interest ↓News Coverage0.40%TXG10x Genomics$26.05-1.3%5 of 5 stars2.58$48.50 86.2%12Gap Down This page (NYSEARCA:SYNB) was last updated on 5/10/2024 by MarketBeat.com Staff From Our PartnersThe ONE AI Stock to own now. (It’s not Nvidia.)Weiss Ratings[Webinar] A Deep Dive into Options Volatility: Skew & Relative ValueOICConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThis 1 Biotech Stock has been shocking the marketsHuge AlertsHe Is Giving Away BitcoinCrypto Swap ProfitsTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 MediaGold Set to EXPLODE!Gold Safe ExchangeCharles Payne Demystifies OptionsUnstoppable Prosperity Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Putnam BioRevolution ETF Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
